pf

Evolva, Cargill Prep Facility for New Stevia Manufacturing

Contact Author
Close
Fill out my online form.

Evolva and Cargill have agreed to begin the engineering phase for converting an existing Cargill manufacturing facility to produce next-generation stevia sweeteners (steviol glycosides). The ingredients are expected to be commercially available in 2016.

(In November 2014, Evolva expanded its fermentation-derived ingredient and intellectual property holdings, particularly for stevia products such as Reb D, Reb M and other steviol glycosides, through its acquisition of Allylix. Read an exclusive interview with Evolva CEO Neil Goldsmith in P&F's February 2015 issue).

These sweeteners will be produced in a Cargill fermentation system in Blair, Nebraska. Using a larger existing facility, the companies said, provides flexibility to expand rapidly and cost-effectively to meet commercial demand.

Under terms of the 2013 joint development agreement between the two companies, Evolva received an option to obtain up to a 45% stake in the business to commercialize the sweeteners. Evolva has informed Cargill that it intends to exercise this 45% option, subject to final terms being agreed between the two companies.

Related Content